Kintara Therapeutics, Inc.

NasdaqCM:KTRA Stock Report

Market Cap: US$8.6m

Kintara Therapeutics, Inc. Company Information

Kintara Therapeutics, Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: Kintara Therapeutics, Inc.
  • Ticker: KTRA
  • Exchange: NasdaqCM
  • Founded: 2009
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$8.589m
  • Shares Outstanding: 55.30m
  • Website: https://www.kintara.com

Number of Employees


Location

  • Kintara Therapeutics, Inc.
  • 9920 Pacific Heights Blvd
  • Suite 150
  • San Diego
  • California
  • 92121
  • United States


Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
KTRANasdaqCM (Nasdaq Capital Market)YesNew Common StockUSUSDJan 2013
3DMADB (Deutsche Boerse AG)YesNew Common StockDEEURJan 2013

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/05/01 00:00
End of Day Share Price 2024/05/01 00:00
Earnings2023/12/31
Annual Earnings2023/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.